Autoradiographic localization of benzodiazepine receptor downregulation

EI Tietz, HC Rosenberg and TH Chiu

Regional differences in downregulation of brain benzodiazepine receptors were studied using a quantitative autoradiographic method. Rats were given a 4-week flurazepam treatment known to cause tolerance and receptor downregulation. A second group of rats was given a similar treatment, but for only 1 week. A third group was given a single acute dose of diazepam to produce a brain benzodiazepine-like activity equivalent to that found after the chronic treatment. Areas studied included hippocampal formation, cerebral cortex, superior colliculus, substantia nigra, dorsal geniculate nucleus, lateral amygdala and lateral hypothalamus. There was a regional variation in the degree of downregulation after 1 week of flurazepam treatment, ranging from 12% to 25%. Extending the flurazepam treatment to 4 weeks caused little further downregulation in those areas studied, except for the pars reticulata of the substantia nigra, which showed a 13% reduction in [3H]flunitrazepam binding after 1 week and a 40% reduction after 4 weeks of treatment. In a few areas, such as the lateral hypothalamus, no significant change in binding was found after 4 weeks. Acute diazepam treatment caused no change in binding. This latter finding as well as results obtained during the development of the methodology show that downregulation was not an artifact due to residual drug content of brain slices. The regional variations in degree and rate of downregulation suggest areas that may be most important for benzodiazepine tolerance and dependence and may be related to the varying time courses for tolerance to different benzodiazepine actions.

Volume 236, Issue 1, pp. 284-292, 01/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. Li, A. Szabo, and H. C. Rosenberg Down-Regulation of Benzodiazepine Binding to alpha 5 Subunit-Containing gamma -Aminobutyric AcidA Receptors in Tolerant Rat Brain Indicates Particular Involvement of the Hippocampal CA1 Region J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 689 - 696. [Abstract] [Full Text]

				E. I. Tietz, X. J. Zeng, S. Chen, S. M. Lilly, H. C. Rosenberg, and P. Kometiani Antagonist-Induced Reversal of Functional and Structural Measures of Hippocampal Benzodiazepine Tolerance J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 932 - 942. [Abstract] [Full Text]

				L. A. Walsh, M. Li, T.-J. Zhao, T. H. Chiu, and H. C. Rosenberg Acute Pentylenetetrazol Injection Reduces Rat GABAA Receptor mRNA Levels and GABA Stimulation of Benzodiazepine Binding with No Effect on Benzodiazepine Binding Site Density J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1626 - 1633. [Abstract] [Full Text]

				T.-J. Zhao, M. Li, T. H. Chiu, and H. C. Rosenberg Decreased Benzodiazepine Binding with Little Effect on gamma -Aminobutyric Acid Binding in Rat Brain After Treatment with Antisense Oligodeoxynucleotide to the gamma -Aminobutyric AcidA Receptor Gamma-2 Subunit J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 752 - 759. [Abstract] [Full Text]

				M. H. J. Tehrani and E. M. Barnes Jr. Sequestration of gamma -Aminobutyric AcidA Receptors on Clathrin-Coated Vesicles During Chronic Benzodiazepine Administration In Vivo J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 384 - 390. [Abstract] [Full Text]

				A. Cittadini and M. Lader Lack of effect of a small dose of flumazenil in reversing short-term tolerance to benzodiazepines in normal subjects J Psychopharmacol, January 1, 1991; 5(3): 220 - 227. [Abstract] [PDF]